BioMedPartners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals
  • Investments
  • 103

  • Portfolio
  • 23

  • Exits
  • 46

Exits

BioMedPartners General Information

Description

Founded in 2003, BioMedPartners is a venture capital firm based in Basel, Switzerland. The firm prefers to invest in life science sector across Central Europe.

Contact Information

Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Mezzanine
Primary Office
  • Elisabethenstrasse 23
  • 4051 Basel
  • Switzerland
+41 061 000 00 00

BioMedPartners Investments (103)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ImmunOs Therapeutics 07-Jun-2022 Later Stage VC 0000 Drug Discovery Generating Revenue 000000 000000 00.0
0000000 03-May-2022 00000 00000 000.00 Biotechnology Pre-Clinical Trials
00000000 16-Mar-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
000000 0000000 10-Mar-2022 00000 00000 000.00 Biotechnology Generating Revenue 0000000 000000 00.0
0000000 25-Aug-2021 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 000000 000000 00.0
00000 000000000000 02-Jul-2021 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 0000000 000000 00.0
0000000 0000000000 15-Jun-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000000 000000000 00.0
00000000 06-Apr-2021 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 000000000 00.0
Noema Pharma 01-Dec-2020 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 0000000 000000000 00.0
Tubulis 21-Jul-2020 Later Stage VC 000.00 Biotechnology Pre-Clinical Trials 0000000 000000 00.0
You’re viewing 10 of 103 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMedPartners Exits (46)

Company Name Exit Date Exit Type Exit Size
Anergis 01-Aug-2021 Bankruptcy: Liquidation
0000000 01-Jun-2021 000000000 00000000
0000000 15-Mar-2021 000000000 00000000
000000000 01-Jan-2020 000 00 00000000
0000 000000000000 15-Jul-2019 000000000000000000 00000
0000000 000000 18-Apr-2019 000 0000
0000000 0000000 11-Feb-2019 000 000.00
00000000 15-May-2018 000 00000
Symetis 16-May-2017 Merger/Acquisition 00000
Idiag 02-May-2017 Secondary Transaction - Private
You’re viewing 10 of 46 exits. Get the full list »

BioMedPartners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore BioMedPartners‘s full profile, request access.

Request a free trial

BioMedPartners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BioMedPartners Team (24)

Name Title Deals Funds Boards Office
Stefan Fäs Chief Financial Officer & Partner Basel, Switzerland
Gerhard Ries Ph.D Co-Founder & General Partner 00 0 0 Basel, Switzerland
Thomas Möller Ph.D General Partner 00 0 0 Basel, Switzerland
Josef Bissig Venture Partner Basel, Switzerland
Karl Deres Venture Partner Basel, Switzerland
You’re viewing 5 of 24 team members. Get the full list »

BioMedPartners Co-Investors (70)

Name With Exits Lead Partner Series Industry
High-Tech Gründerfonds 4 0 0 Series chart Industry bar
Schroders Capital 0 0 0 Series chart Industry bar
Andera Partners 0 0 Series chart Industry bar
Gimv 0 0 Series chart Industry bar
Inkef 0 0 Series chart Industry bar
You’re viewing 5 of 70 co-investors. Get the full list »